Procter & Gamble CO Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Freddy P. Bharucha, CEO - Beauty of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Shailesh Jejurikar, Chairman, President and CEO and a Director of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
El Hak Hesham Abd, CEO-Baby and Feminine Care of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Moses Victor Javier Aguilar, Chf Rsch, Dev & Innov Officer of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Paul Gama, CEO- Health Care of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
De Azevedo Juliana Monteiro Santos, CEO - Grooming of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Andre Schulten, Chief Financial Officer of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Susan Street Whaley, Chief Legal Officer & Secy of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Sundar G. Raman, CEO-Fabric Home & Habitat Care of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Balaji Purushothaman, Chief Human Resources Officer of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Marc S. Pritchard, Chief Brand Officer of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Matthew W. Janzaruk, SVP - Chief Accounting Officer of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Jon R Moeller, Retired Chairman of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Procter & Gamble Director Robert Portman acquired 5,155.46 shares of common stock through a Restricted Stock Unit award.
NYSE
Procter & Gamble Director Ashley McEvoy acquired 202 shares of common stock through a grant of Restricted Stock Units.
NYSE
Christine M. McCarthy, a Director at Procter & Gamble, acquired 253 shares of common stock on June 9, 2026.
NYSE
Christopher J. Kempczinski, a Director at Procter & Gamble, acquired 258 shares of common stock on June 9, 2026, as part of a restricted stock unit award.
NYSE
Procter & Gamble Director Joseph Jimenez acquired 320 shares of common stock through restricted stock units.
NYSE
Procter & Gamble Director Craig Arnold acquired 202 shares of common stock on June 9, 2026, as part of a restricted stock unit award.
NYSE
Procter & Gamble amends a previous filing to correct an administrative error regarding a director's Restricted Stock Unit award.
NYSE
Procter & Gamble's CEO of Baby, Fem & Family Care reported sales of common stock and acquisition of restricted stock units under a 10b5-1 plan.
NYSE
Procter & Gamble's Chief Legal Officer, Susan Street Whaley, reported a sale of common stock and an acquisition of Restricted Stock Units.
NYSE
Procter & Gamble's Chief R&D Officer, Moses Aguilar, exercised stock options and subsequently sold an equal number of shares.
NYSE
Procter & Gamble's Chief Human Resources Officer, Balaji Purushothaman, exercised stock options and subsequently sold the acquired common stock for a significant gain.
NYSE
Procter & Gamble's Executive Chairman, Jon R. Moeller, exercised stock options and subsequently sold a significant number of common shares.
NYSE
Gary A. Coombe, CEO Grooming at Procter & Gamble, exercised stock options and subsequently sold an equal number of common shares under a 10b5-1 plan.
NYSE
A Procter & Gamble Co. executive, Ma. Fatima Francisco, sold 8,000 shares of common stock for $158 per share, totaling $1.26 million.
NYSE
Procter & Gamble's Chief Brand Officer, Marc S. Pritchard, exercised stock options and subsequently sold the acquired shares, as disclosed in a recent Form 4 filing.
NYSE
Procter & Gamble Director Robert Portman acquired 54 shares of common stock through a Restricted Stock Unit award on December 9, 2025.
NYSE
Procter & Gamble Director Ashley McEvoy was awarded 215 shares of common stock as part of the company's 2025 Stock and Incentive Compensation Plan.